The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection
Open accessAbstract
BACKGROUND: Currently, there is no effective intervention for a primary cytomegalovirus (CMV) infection during pregnancy. METHODS: We studied pregnant women with a primary CMV infection. The therapy group comprised women whose amniotic fluid contained either CMV or CMV DNA and who were offered intravenous CMV hyperimmune globulin at a dose of 200 U per kilogram of maternal weight. A prevention group, consisting of women with a recent primary infection before 21 weeks' gestation or who declined amniocentesis, was offered monthly hyperimmune globulin (100 U per kilogram intravenously). RESULTS: In the therapy group, 31 women received hyperimmune globulin, only 1 (3 percent) of whom gave birth to an infant with CMV disease (symptomatic at birth and handicapped at two or more years of age), as compared with 7 of 14 women who did not receive hyperimmune globulin (50 percent). Thus, hyperimmune globulin therapy was associated with a significantly lower risk of congenital CMV disease (adjusted odds ratio, 0.02; 95 percent confidence interval, -infinity to 0.15; P<0.001). In the prevention group, 37 women received hyperimmune globulin, 6 (16 percent) of whom had infants with congenital CMV infection, as compared with 19 of 47 women (40 percent) who did not receive hyperimmune globulin. Thus, hyperimmune globulin therapy was associated with a significantly lower risk of congenital CMV infection (adjusted odds ratio, 0.32; 95 percent confidence interval, 0.10 to 0.94; P=0.04). Hyperimmune globulin therapy significantly (P<0.001) increased CMV-specific IgG concentrations and avidity and decreased natural killer cells and HLA-DR+ cells and had no adverse effects. CONCLUSIONS: Treatment of pregnant women with CMV-specific hyperimmune globulin is safe, and the findings of this nonrandomized study suggest that it may be effective in the treatment and prevention of congenital CMV infection. A controlled trial of this agent may now be appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status
Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J., & Alford, C. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261003 · Cited by 1,084
Stagno, S. (1986) · JAMA · doi:10.1001/jama.256.14.1904 · Cited by 960
Snydman, D. R., Werner, B. G., Heinze-Lacey, B., Berardi, V. P., Tilney, N. L., Kirkman, R. L., Milford, E. L., Cho, S. I., Bush, H. L., Levey, A. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171703 · Cited by 570
Specific and nonspecific NK cell activation during virus infection
Dokun, A. O., Kim, S., Smith, H. R. C., Kang, H.-S. P., Chu, D. T., & Yokoyama, W. M. (2001) · Nature Immunology · doi:10.1038/ni714 · Cited by 477
Maternal Immunity and Prevention of Congenital Cytomegalovirus Infection
Fowler, K. B., Stagno, S., & Pass, R. F. (2003) · JAMA · doi:10.1001/jama.289.8.1008 · Cited by 440
Passive immunity in prevention and treatment of infectious diseases
Keller, M. A., & Stiehm, E. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.602 · Cited by 388
From Infection to Autoimmunity
Fairweather, D., Kaya, Z., Shellam, G. R., Lawson, C. M., & Rose, N. R. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0492 · Cited by 328
Herpesvirus Infections of Pregnancy
Stagno, S., & Whitley, R. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132006 · Cited by 291
A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant
Pass, R. F., Duliegè, A., Boppana, S., Sekulovich, R., Percell, S., Britt, W., & Burke, R. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/315022 · Cited by 249
Grangeot‐Keros, L., Mayaux, M. J., Lebon, P., Freymuth, F., Eugene, G., Stricker, R., & Dussaix, E. (1997) · The Journal of Infectious Diseases · doi:10.1086/513996 · Cited by 240
Cytomegalovirus and Child Day Care
Adler, S. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211903 · Cited by 194
Self-citationAssessment of Gestational Age and Development at Birth
Lubchenco, L. O. (1970) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)32381-1 · Cited by 161
Antibodies for the prevention and treatment of viral diseases
Sawyer, L. A. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00111-x · Cited by 127
Interactions of Cytomegalovirus with the Human Immune System
Rook, A. H. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.supplement_3.s460 · Cited by 110
Safety and immunogenicity of the Towne strain cytomegalovirus vaccine
Adler, S. P., Hempfling, S., Starr, S. E., et al. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199803000-00006 · Cited by 88
Self-citationHyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction
Nigro, G., Torre, R. L., Anceschi, M. M., Mazzocco, M., & Cosmi, E. V. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70620-4 · Cited by 56
Self-citationClinical uses of intravenous immunoglobulin in pregnancy
Clark, A. L., & Gall, S. A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)80043-9 · Cited by 50
Human cytomegalovirus and immunopathology
Sissons, J. G. P., Carmichael, A. J., McKinney, N., et al. (2002) · Springer Seminars in Immunopathology · doi:10.1007/s00281-002-0104-0 · Cited by 40
Natural Killer Cell Activity in Infants and Children Excreting Cytomegalovirus
Harrison, C. J., & Waner, J. L. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.2.301 · Cited by 19
Cited by
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
The “Silent” Global Burden of Congenital Cytomegalovirus
Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B., & Gupta, R. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-12 · Cited by 1,028
Rawlinson, W. D., Boppana, S. B., Fowler, K. B., Kimberlin, D. W., Lazzarotto, T., Alain, S., Daly, K., Doutré, S., Gibson, L., Giles, M. L., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30143-3 · Cited by 841
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Crough, T., & Khanna, R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-08 · Cited by 644
Hearing Loss and Congenital CMV Infection: A Systematic Review
Goderis, J., De Leenheer, E., Smets, K., Van Hoecke, H., Keymeulen, A., & Dhooge, I. (2014) · Pediatrics · doi:10.1542/peds.2014-1173 · Cited by 586
Metadata
- Authors
- Nigro, G., Adler, S. P., La Torre, R., & Best, A. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-09-29
- Volume
- 353
- Issue
- 13
- Pages
- 1350-1362
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2165012523
- Cited by
- 784
- References
- 21
- FWCI
- 22.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.